Prognostic Markers and Trials in Penile Cancer

New tumor biomarkers open the potential for designing personalized therapy for penile squamous cell carcinoma. Despite the initial promising results of some biomarkers, controversy remains due to contradictory studies. Further robust research work is required before incorporating biomarkers in the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Naushad, Naufal, Deb, Abdalla A., Agag, Ayman A., Serag, Hosam A., Sangar, Vijay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Association of Urology 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346112/
https://www.ncbi.nlm.nih.gov/pubmed/37877863
http://dx.doi.org/10.5152/tud.2023.22225
_version_ 1785073237848227840
author Naushad, Naufal
Deb, Abdalla A.
Agag, Ayman A.
Serag, Hosam A.
Sangar, Vijay K.
author_facet Naushad, Naufal
Deb, Abdalla A.
Agag, Ayman A.
Serag, Hosam A.
Sangar, Vijay K.
author_sort Naushad, Naufal
collection PubMed
description New tumor biomarkers open the potential for designing personalized therapy for penile squamous cell carcinoma. Despite the initial promising results of some biomarkers, controversy remains due to contradictory studies. Further robust research work is required before incorporating biomarkers in the personalized management of penile cancer. This narrative review aims to highlight some of the most commonly and recently investigated biomarkers of penile cancer and to summarize the ongoing registered clinical trials for the management of penile cancer patients.
format Online
Article
Text
id pubmed-10346112
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Turkish Association of Urology
record_format MEDLINE/PubMed
spelling pubmed-103461122023-07-15 Prognostic Markers and Trials in Penile Cancer Naushad, Naufal Deb, Abdalla A. Agag, Ayman A. Serag, Hosam A. Sangar, Vijay K. Urol Res Pract Review New tumor biomarkers open the potential for designing personalized therapy for penile squamous cell carcinoma. Despite the initial promising results of some biomarkers, controversy remains due to contradictory studies. Further robust research work is required before incorporating biomarkers in the personalized management of penile cancer. This narrative review aims to highlight some of the most commonly and recently investigated biomarkers of penile cancer and to summarize the ongoing registered clinical trials for the management of penile cancer patients. Turkish Association of Urology 2023-05-01 /pmc/articles/PMC10346112/ /pubmed/37877863 http://dx.doi.org/10.5152/tud.2023.22225 Text en © 2023 authors https://creativecommons.org/licenses/by/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Review
Naushad, Naufal
Deb, Abdalla A.
Agag, Ayman A.
Serag, Hosam A.
Sangar, Vijay K.
Prognostic Markers and Trials in Penile Cancer
title Prognostic Markers and Trials in Penile Cancer
title_full Prognostic Markers and Trials in Penile Cancer
title_fullStr Prognostic Markers and Trials in Penile Cancer
title_full_unstemmed Prognostic Markers and Trials in Penile Cancer
title_short Prognostic Markers and Trials in Penile Cancer
title_sort prognostic markers and trials in penile cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346112/
https://www.ncbi.nlm.nih.gov/pubmed/37877863
http://dx.doi.org/10.5152/tud.2023.22225
work_keys_str_mv AT naushadnaufal prognosticmarkersandtrialsinpenilecancer
AT debabdallaa prognosticmarkersandtrialsinpenilecancer
AT agagaymana prognosticmarkersandtrialsinpenilecancer
AT seraghosama prognosticmarkersandtrialsinpenilecancer
AT sangarvijayk prognosticmarkersandtrialsinpenilecancer

Ejemplares similares